Efficacy, Safety, and Tolerability of Once-Daily Niacin for Dyslipidemia – (07-25-02)



Efficacy, Safety, and Tolerability of Once-Daily Niacin for Dyslipidemia

The dosages used in this study (1,000 and 1,500 mg) are very reasonable and low enough to avoid most side effects (most notable is flushing). Participants had elevations of HDL up to 25%, which is a large jump unmatched by most pharmaceuticals (most don’t touch HDL levels).

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: